Targeted delivery of HGF to the skeletal muscle improves glucose homeostasis in diet-induced obese mice

Journal of Physiology and Biochemistry

Volumn 71, Issue 4, 2015, Pages 795-805

  Sanchez Encinales, Viviana ^a   Cozar Castellano, Irene ^a,b   Garcia Ocaña, Adolfo ^c   Perdomo, Germán ^a,d  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Hepatocyte growth factor; Insulin resistance; Obesity; Skeletal muscle

Indexed keywords

GLUCOSE; GLUCOSE BLOOD LEVEL; HGF PROTEIN, MOUSE; INSULIN; SCATTER FACTOR;

ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENE TARGETING; GENETICS; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; LIPID DIET; LIPID METABOLISM; MALE; METABOLISM; OBESITY; PHYSIOLOGY; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; DIET, HIGH-FAT; GENE TARGETING; GLUCOSE; HEPATOCYTE GROWTH FACTOR; HOMEOSTASIS; INSULIN; LIPID METABOLISM; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; OBESITY; TRANSCRIPTIONAL ACTIVATION;

EID: 84949319409     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-015-0444-6     Document Type: Article

References (31)

1. Araujo TG, Oliveira AG, Carvalho BM, Guadagnini D, Protzek AO, Carvalheira JB, Boschero AC, Saad MJ (2012) Hepatocyte growth factor plays a key role in insulin resistance-associated compensatory mechanisms. Endocrinology 153:5760–5769
2. Bell LN, Ward JL, Degawa-Yamauchi M, Bovenkerk JE, Jones R, Cacucci BM, Gupta CE, Sheridan C, Sheridan K, Shankar SS, Steinberg HO, March KL, Considine RV (2006) Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity. Am J Physiol Endocrinol Metab 291:E843–E848
3. Bertola A, Bonnafous S, Cormont M, Anty R, Tanti JF, Tran A, Le Marchand-Brustel Y, Gual P (2007) Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway. J Biol Chem 282:10325–10332
4. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802–804
5. de Courten B, de Courten MP, Dougherty S, Forbes JM, Potts JR, Considine RV (2013) Insulin infusion reduces hepatocyte growth factor in lean humans. Metabolism 62:647–650
6. Fafalios A, Ma J, Tan X, Stoops J, Luo J, Defrances MC, Zarnegar R (2011) A hepatocyte growth factor receptor (Met)-insulin receptor hybrid governs hepatic glucose metabolism. Nat Med 17:1577–1584
7. Fiaschi-Taesch NM, Santos S, Reddy V, Van Why SK, Philbrick WF, Ortega A, Esbrit P, Orloff JJ, Garcia-Ocana A (2004) Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: the efficacy of parathyroid hormone-related protein and hepatocyte growth factor. J Am Soc Nephrol 15:112–125
8. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581–1586
9. Formiguera X, Canton A (2004) Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol 18:1125–1146
10. Ghersa P, Gobert RP, Sattonnet-Roche P, Richards CA, Merlo Pich E, Hooft van Huijsduijnen R (1998) Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther 5:1213–1220
11. Grill MA, Bales MA, Fought AN, Rosburg KC, Munger SJ, Antin PB (2003) Tetracycline-inducible system for regulation of skeletal muscle-specific gene expression in transgenic mice. Transgenic Res 12:33–43
12. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444:860–867
13. Jimenez-Palomares M, Ramos-Rodriguez JJ, Lopez-Acosta JF, Pacheco-Herrero M, Lechuga-Sancho AM, Perdomo G, Garcia-Alloza M, Cozar-Castellano I (2012) Increased Abeta production prompts the onset of glucose intolerance and insulin resistance. Am J Physiol Endocrinol Metab 302:E1373–E1380
14. Kataoka H, Miyata S, Uchinokura S, Itoh H (2003) Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Rev 22:223–236
15. Kato Y, Yu D, Schwartz MZ (1998) Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection. J Pediatr Surg 33:13–15
16. Liu Y, Sweeney G (2014) Adiponectin action in skeletal muscle. Best Pract Res Clin Endocrinol Metab 28:33–41
17. Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111–2117
18. Nakamura T, Nawa K, Ichihara A (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 122:1450–1459
19. Perdomo G, Martinez-Brocca MA, Bhatt BA, Brown NF, O’Doherty RM, Garcia-Ocana A (2008) Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J Biol Chem 283:13700–13706
20. Rehman J, Considine RV, Bovenkerk JE, Li J, Slavens CA, Jones RM, March KL (2003) Obesity is associated with increased levels of circulating hepatocyte growth factor. J Am Coll Cardiol 41:1408–1413
21. Roccisana J, Reddy V, Vasavada RC, Gonzalez-Pertusa JA, Magnuson MA, Garcia-Ocana A (2005) Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass. Diabetes 54:2090–2102
22. Stuart KA, Riordan SM, Lidder S, Crostella L, Williams R, Skouteris GG (2000) Hepatocyte growth factor/scatter factor-induced intracellular signalling. Int J Exp Pathol 81:17–30
23. Sun K, Kusminski CM, Scherer PE (2011) Adipose tissue remodeling and obesity. J Clin Invest 121:2094–2101
24. Swierczynski J, Korczynska J, Goyke E, Adrych K, Raczynska S, Sledzinski Z (2005) Serum hepatocyte growth factor concentration in obese women decreases after vertical banded gastroplasty. Obes Surg 15:803–808
25. Tatsumi R, Liu X, Pulido A, Morales M, Sakata T, Dial S, Hattori A, Ikeuchi Y, Allen RE (2006) Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. Am J Physiol Cell Physiol 290:C1487–C1494
26. Tsukagawa E, Adachi H, Hirai Y, Enomoto M, Fukami A, Ogata K, Kasahara A, Yokoi K, Imaizumi T (2013) Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10-year prospective study. Clin Endocrinol (Oxf) 79:43–48
27. Visiedo F, Bugatto F, Carrasco-Fernandez C, Saez-Benito A, Mateos RM, Cozar-Castellano I, Bartha JL, Perdomo G (2015) Hepatocyte growth factor is elevated in amniotic fluid from obese women and regulates placental glucose and fatty acid metabolism. Placenta 36:381–388
28. Visscher TL, Seidell JC (2001) The public health impact of obesity. Annu Rev Public Health 22:355–375
29. Wei Y, Chen K, Whaley-Connell AT, Stump CS, Ibdah JA, Sowers JR (2008) Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. Am J Physiol Regul Integr Comp Physiol 294:R673–R680
30. Yamada M, Tatsumi R, Kikuiri T, Okamoto S, Nonoshita S, Mizunoya W, Ikeuchi Y, Shimokawa H, Sunagawa K, Allen RE (2006) Matrix metalloproteinases are involved in mechanical stretch-induced activation of skeletal muscle satellite cells. Muscle Nerve 34:313–319
31. Yuasa T, Kakuhata R, Kishi K, Obata T, Shinohara Y, Bando Y, Izumi K, Kajiura F, Matsumoto M, Ebina Y (2004) Platelet-derived growth factor stimulates glucose transport in skeletal muscles of transgenic mice specifically expressing platelet-derived growth factor receptor in the muscle, but it does not affect blood glucose levels. Diabetes 53:2776–2786